Cumberland Pharmaceutical... (CPIX)

NASDAQ: CPIX · Real-Time Price · USD

4.62

-0.19 (-3.95%)

At close: May 02, 2025, 2:59 PM

Cumberland Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	17.96M	18.32M	19.76M	27.04M	24.75M	28.21M	27.94M	45.41M	34.51M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	8.29M	4.67M	15.62M
Long-Term Investments	n/a	n/a	n/a	n/a	-662.01K	n/a	n/a	n/a	n/a
Other Long-Term Assets	13.79M	15.5M	10.05M	12.47M	14.89M	18.85M	2.53M	2.49M	2.12M
Receivables	11.7M	9.76M	13.16M	6.88M	12.38M	7.86M	7.84M	8.4M	7.33M
Inventory	4M	4.61M	9.4M	8.43M	10.64M	8.87M	27.83M	6.74M	5.37M
Other Current Assets	2,786.5B	3.03M	3.08M	3.34M	n/a	2.46M	n/a	n/a	n/a
Total Current Assets	36.45M	35.71M	45.87M	45.69M	49.97M	50.16M	74.87M	68.68M	65.55M
Property-Plant & Equipment	6.45M	7.04M	5.5M	1.47M	2.6M	3.71M	771.21K	528.88K	464.45K
Goodwill & Intangibles	18.89M	23.52M	31.5M	24.84M	29M	31.8M	34.44M	21.44M	22.15M
Total Long-Term Assets	39.13M	46.06M	47.05M	38.77M	46.49M	54.39M	37.83M	24.55M	27.86M
Total Assets	75,583.4B	81.78M	92.93M	84.46M	96.46M	104.55M	112.69M	93.23M	93.4M
Account Payables	13.91M	14.04M	10.82M	9.64M	13.4M	9.99M	11.09M	8.98M	8.04M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	5.5M	n/a	n/a	n/a
Short-Term Debt	5.1M	n/a	n/a	n/a	2.19M	n/a	n/a	n/a	n/a
Other Current Liabilities	12.25M	12.4M	16.15M	7.33M	8.07M	11.94M	15.45M	6.33M	5.45M
Total Current Liabilities	31.62M	27.98M	28.58M	19.28M	25.67M	24.15M	27.8M	17.69M	14.79M
Long-Term Debt	10.18M	12.78M	16.2M	15M	15M	18.5M	20M	9.8M	4.1M
Other Long-Term Liabilities	6.3M	6.45M	7.59M	7.49M	7.86M	8.74M	9.32M	1.82M	1.39M
Total Long-Term Liabilities	21.42M	24.53M	28.37M	22.58M	23.92M	29.31M	29.32M	11.62M	5.49M
Total Liabilities	53.04M	52.52M	56.95M	41.86M	49.59M	53.46M	57.12M	29.31M	20.28M
Total Debt	20.57M	18.43M	20.96M	16.06M	17.08M	21.5M	20M	9.8M	4.1M
Common Stock	46.82M	47.09M	47.47M	48.45M	49.12M	49.91M	51.1M	52.41M	54.64M
Retained Earnings	-23.97M	-17.49M	-11.21M	-5.64M	-2.13M	1.21M	4.75M	11.71M	18.6M
Comprehensive Income	n/a	n/a	n/a	0.00	-0.00	-0.00	-0.00	0.00	n/a
Shareholders Equity	22.85M	29.6M	36.27M	42.81M	46.99M	51.12M	55.84M	64.12M	73.25M
Total Investments	-17,964.2B	n/a	n/a	n/a	-662.01K	n/a	8.29M	4.67M	15.62M